Number of subjects (%) | ||||
---|---|---|---|---|
Total (n = 91) | POBA (n = 65) | PCB (n = 26) | p-value | |
Mean Age, years (±sd) | 65.3 ± 10.6 | 64.7 ± 10.4 | 66.6 ± 11.3 | .461 |
Mean BMI, kg/m2 (±sd) | 26.4 ± 5.1 | 26.1 ± 4.6 | 27.0 ± 6.3 | .532 |
Gender | ||||
Female | 49 (53.8) | 36 (55.4) | 13 (50.0) | .816 |
Male | 42 (46.2) | 29 (44.6) | 13 (50.0) | |
Ethnic Group | ||||
Chinese | 62 (68.1) | 44 (67.7) | 18 (69.2) | .552 |
Malay | 25 (27.5) | 19 (29.2) | 6 (23.1) | |
Indian | 4 (4.4) | 2 (3.1) | 2 (7.7) | |
Smoker | 14 (15.4) | 9 (13.8) | 5 (19.2) | .532 |
Co-Morbidities (%) | ||||
Hypertension | 90 (98.9) | 64 (98.5) | 26 (100) | 1.00 |
Hyperlipidemia | 77 (84.6) | 56 (86.2) | 21 (80.8) | .532 |
Diabetes | 67 (73.6) | 47 (72.3) | 20 (76.9) | .851 |
Nephropathy | 57 (62.6) | 38 (58.5) | 19 (73.1) | .288 |
Retinopathy | 36 (39.6) | 27 (41.5) | 9 (34.6) | .709 |
Neuropathy | 12 (13.2) | 8 (12.3) | 4 (15.4) | .737 |
Coronary Artery Disease | 41 (45.1) | 29 (44.6) | 12 (46.2) | 1.00 |
Cerebrovascular Accident | 9 (9.9) | 5 (7.7) | 4 (15.4) | .270 |
Malignancy | 8 (8.8) | 4 (6.2) | 4 (15.4) | .219 |
Asthma | 3 (3.3) | 3 (4.6) | 0 | .555 |
Access Side | ||||
Left | 61 (67.0) | 41 (63.1) | 20 (76.9) | .307 |
Right | 30 (33.0) | 24 (36.9) | 6 (23.1) | |
Access Type | ||||
Brachiocephalic | 86 (94.5) | 61 (93.8) | 25 (96.2) | 1.00 |
Radiocephalic | 5 (5.5) | 4 (6.2) | 1 (3.8) | |
Access Patency | ||||
Recurrent | 59 (64.8) | 41 (63.1) | 18 (69.2) | .755 |
De novo | 32 (35.2) | 24 (36.9) | 8 (30.8) | |
Mean Access Age, months (25th, 75th percentile) | 62 (35, 145) | 52 (36, 144) | 71 (28, 171) | .857 |
Medical History | ||||
Statin | 73 (80.2) | 51 (78.5) | 22 (84.6) | .708 |
Beta Blocker | 61 (67.0) | 44 (67.7) | 17 (65.4) | 1.00 |
Antiplatelet | 60 (65.9) | 42 (64.6) | 18 (69.2) | .861 |
Antidiabetic agents | 50 (54.9) | 37 (56.9) | 13 (50.0) | .714 |
Warfarin | 7 (7.7) | 3 (4.6) | 4 (15.4) | .100 |